Navigation Links
Dissectron Ultrasonic Aspirator

ProductsDissectron Ultrasonic Aspirator
Company Integra LifeSciences Corporation
Item Dissectron Ultrasonic Aspirator
Features The ultrasonic handpiece profile has been designed to allow outstanding visibility of the working area together with safety and precision. DISSECTRON Portable Unit is one of the most user-friendly ultrasonic surgical aspirators on the market outside the United States.
Description Dissectron ultrasonic aspirator, portable unit is an ultrasonic surgical aspirator for the fragmentation and emulsification of tissue available only outside the united states. Gathers in a very compact design all the technologies required for operating a high-end instrument.
Info Integra LifeSciences Corporation
Customer Service: (800) 654-2873

Related medicine products :

1. Ultrasonic Pachymeter UP-1000
2. Compact Ultrasonic Phacoemulsification System
3. cusa selector™ Ultrasonic Aspirator
4. CUSA Excel Ultrasonic Surgical Aspirator
5. OSCAR Ultrasonic Bone Cement Remover
6. Ultrasonic Pachometer
7. The Ultrasonic BioMicroscope (UBM P40)
8. The P45 Ultrasonic Workstation
9. UD-6000 Ultrasonic A/B Scanner and Biometer
10. UD-1000 Ultrasonic B-Scanner
11. DGH Pachette 3 Ultrasonic Pachymeter
... an innovative handheld device for ... non-invasively, comfortably, and accurately.,It is, ... than an automatic blood pressure ... charge, Vasotrax will take approximately ...
... Insulin-like growth factor II (IGF-II) is a 7.5 ... liver and is postulated to have mitogenic and ... of IGF-II are mediated by binding to target ... the Type II IGF receptor, a monomeric protein ...
... Pregnancy-associated plasma protein A (PAPP-A) is ... is produced in high concentrations by ... into the maternal circulation in increasing ... PAPP-A is not specific to pregnancy ...
... Pregnancy-associated plasma protein A (PAPP-A) ... PAPP-A is produced in high concentrations ... released into the maternal circulation in ... [1]. PAPP-A is not specific to ...
Medicine Products:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: